Higher heart risk seen with Abbott dissolving stent after tw
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's widely used Xience drug-coated metal stent two years after implantation, according to data presented on Saturday.

New guidelines for blood vessel size and proper implantation techniques put in place for the new Absorb stent since the study began, however, should lead to better results, researchers said. They reported that 19 percent of those who received Absorb in the 2,008-patient trial had it implanted in blood vessels now deemed too small for the device, hurting overall results.

http://in.reuters.com/article/us-heart-abbott-stent-idINKBN16P0IV
Preview
Dr. s●●●●v v●●s and 1 others like this
Like
Comment
Share